modelJ01DD07

Diagram of J01DD07

Extends from Pharmacokinetic.Models.PK_2C.

Information

name:Ceftizoxime
ATC code:J01DD07
route:intravenous
compartments:2
dosage:1000mg
volume of distribution:11.4L
clearance:100mL/min
other parameters in model implementation

Ceftizoxime is a third-generation cephalosporin antibiotic indicated for the treatment of a variety of bacterial infections including respiratory tract, urinary tract, skin and soft tissue infections. It was previously widely used but has been largely replaced by newer agents and is not commonly used today.

Pharmacokinetics

Pharmacokinetic parameters reported for healthy adult volunteers after single intravenous injection.

References

  1. Karna, P, et al., & Gooch, WM (1993). Population pharmacokinetics of ceftizoxime in premature newborns. Developmental pharmacology and therapeutics 20(3-4) 135–143. DOI:10.1159/000457554 PUBMED:https://pubmed.ncbi.nlm.nih.gov/7828445

  2. Facca, B, et al., & Triesenberg, S (1998). Population pharmacokinetics of ceftizoxime administered by continuous infusion in clinically ill adult patients. Antimicrobial agents and chemotherapy 42(7) 1783–1787. DOI:10.1128/AAC.42.7.1783 PUBMED:https://pubmed.ncbi.nlm.nih.gov/9661021

  3. Blouin, RA, et al., & Stoeckel, K (1989). Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects. Antimicrobial agents and chemotherapy 33(3) 291–296. DOI:10.1128/AAC.33.3.291 PUBMED:https://pubmed.ncbi.nlm.nih.gov/2729925

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.VolumeVdp (from PK_2C)VdpPerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdpPerKg (from PK_2C)0.9Volume of distribution peripheral(l/kg)
Pharmacolibrary.Types.Clearancek12 (from PK_2C)1intercompartmental C-P clearance
Pharmacolibrary.Types.Clearancek21 (from PK_2C)1intercompartmental P-C clearance

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)
Interfaces.ConcentrationPort_bperipheralCPort (from PK_2C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral1 (from PK_2C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral (from PK_2C)

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)